ESR1 and breast cancer: To test the effects of miR526b and miR655 in oxidative stress in breast cancer, we used an estrogen receptor (ER)-positive, poorly metastatic breast cancer cell line, MCF7, and highly aggressive, miR526b/miR655-overexpressing MCF7-miR526b and MCF7-miR655 cell lines.